CytoDyn Adjusts Seasonal Components of Its Pre-Flu Vaccine for World Health Organization Recommendations

SANTA FE, N.M.--(BUSINESS WIRE)--CytoDyn, Inc. (Pink Sheets: CYDY) is adjusting the seasonal components of its pre-flu vaccine to accommodate the recent recommendations of the World Health Organization (WHO). The global health agency reports that it now expects the Solomon Islands strain of H1N1 influenza A, and the Wisconsin strain of H3N2 Influenza A, to predominate during next winter’s flu season, replacing the New Caledonia Strain of H1N1 and Panama Strain of H3N2, respectively.